LillyPod is now live to power faster, smarter drug discovery
Eli Lilly and NVIDIA have activated LillyPod, an in-house AI supercomputer featuring over 1,000 NVIDIA Blackwell Ultra GPUs and more than 9,000 petaflops of AI performance. The system supports molecular design, single-cell analysis, and large-scale modeling under a $1 billion, five-year AI partnership, with commitments for regulatory compliance, secure model access via Lilly TuneLab, and 100% renewable power by 2030. Lilly positions the platform to accelerate drug discovery and longevity research while offering controlled external access for biotech partners.
Why it mattersLillyPod uses over 1,000 NVIDIA GPUs under a $1 billion plan; investors should reassess startup valuation and competitive differentiation.
People Mentioned
Kyle Umipig